Total cost (€ billions) | ||
---|---|---|
Screening | 0.03 | |
Treatment/prevention of complications | 2.5 | |
Glycemic control | 1.7 | |
Screening of complications | 0.1 | |
Prevention of cardiovascular complications | 0.8 | |
Treatment of diabetes-related complications | 4.2 | |
Cardiovascular | 0.8 | |
Renal insufficiency | 0.7 | |
Neuropathy | 0.3 | |
Vision loss | 0.1 | |
Other complications | 0.3 | |
Health expenditure indirectly related to diabetes* | 3.6 | |
Health expenditure unrelated to diabetes** | 7.4 | |
Total health expenditure for patients with treated diabetes | 17.7 |